Official Title
Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.
Brief Summary

The aim of this project is to evaluate the impact of pandemic and nonconfinement related to anxiety and eventual immune diseases with several standardized questionnaires : Implant Stability Quotient (ISQ) , Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9), Post Traumatic Stress Disorder-8 (PTSD-8), and Experiences in Close Relationship Scale (ECRS).

Detailed Description

The COVID-19 pandemic and prevention strategise have strongly impacted family lives, social
lives, professional lives, and income; resulting in increased reporting of stress and anxiety
within patients. This risk of infection 'post-confinement' is an additional source of stress
for people returning to their professional and social lives. There are evidence showing a
relationship between stress, immunity and the prognosis of several infections and
inflammatory diseases.

The COVID-19 pandemic and prevention strategise have strongly impacted family lives and
induced a high level of anxiety and other types of stress. This risk of infection
'post-confinement' is an additional source of stress for people returning to their
professional and social life.

There are evidences showing a relationship between stress, immunity and the prognosis of
several infections and inflammatory diseases.

The aim of this project is to launch an online survey that measures population stress felt
during the pandemic and post-confinement time and possible effects on eventual immune
mediated disorders (allergies, auto-immunity..) through the report of new events or flares.
The stress will first be measured on standardized anxiety GAD-7scale but also on more
parameters (ISQ, PHQ-9, PTSD-8, and ECR-S). Socio-economic and environmental parameters will
be recorded.

Level of anxiety and other stress parameters as well as occurrence of inflammatory events
will be measured according to the calendar and confinement /post confinement timing. Risk
factors will be looked for, by multi parametric data analysis.

The survey has been built in a user-friendly, accessible way so the investigators can expect
a high number of participants (at least 400), especially as people are highly concerned by
the situation and will be motivated to take part.

Terminated
Stress Disorder

Diagnostic Test: Generalized Anxiety Disorder-7 (GAD 7)

test that will evaluate persistent and excessive worry about a number of different things. People with Generalized Anxiety Disorder may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with Generalized Anxiety Disorder find it difficult to control their worry.

Diagnostic Test: Background questionnaire

questionnaire on the living conditions, socio-professional contexts and environmental conditions of the participants

Diagnostic Test: Impact of COVID-19 questionnaire

status of the patient with regard to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus)

Diagnostic Test: Confinement and Communication During the COVID-19 Pandemic

know the experience of containment and isolation during the pandemic

Diagnostic Test: Mental Health questionnaire

welfare effect

Diagnostic Test: Patient Health Questionnaire (PHQ-9)

assess depression during the pandemic

Diagnostic Test: Post Traumatic Stress Disorder questionnaire (PTSD-8)

Assessing the trauma of subjects during the pandemic

Diagnostic Test: Experiences in Close Relationship Scale questionnaire (ECR-S)

Measuring social ties and attachment of subjects

Eligibility Criteria

Inclusion Criteria:

- Adult volunteer who agreed to answer the questionnaires

- Age ≥ 18 years old

- Adult affiliated or having a duty to a social security scheme

Exclusion Criteria:

- Children under 18 years old

- Inability to understand information letter, consent, or to use online questionnaire

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
United Kingdom
Locations

Centre Hospitalier Universitaire de Saint-Etienne
Saint-Étienne, France

Centre de Recherche et d'Innovation Clinique
Glasgow, United Kingdom

Claude LAMBERT, MD PhD HDR, Principal Investigator
CHU Saint-Etienne

Centre Hospitalier Universitaire de Saint Etienne
NCT Number
Keywords
Covid-19
Stress
Effects on Immunity
Anxiety
MeSH Terms
COVID-19